SSAs have previously been hypothesised to elicit their mechanism of antibacterial action through selective phospholipid membrane adhesion and permeation events. Analysis of PF and MAF data (Table , Figure ) suggested that co-formulation of the SSAs could either maintain or alter phospholipid membrane affinity and permeability properties of the SSA. These findings would seem to correlate with the results of these antibiofilm studies, with confirmation of the SSAs either causing the individual agent's activity to be maintained or minimised.